7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 
      
    		                             
      total revenue
    		265,196,000 232,088,000 203,471,000 201,814,000 191,476,000 177,235,000 168,491,000 155,054,000 143,030,000 137,150,000 128,714,000 126,891,000 117,404,000 109,144,000 96,099,000 108,108,000 94,779,000 92,101,000 78,665,000 78,316,000 74,569,000 66,335,000 67,510,000 62,897,000 60,848,000 53,975,000 36,655,000 32,873,000 21,692,000 
      yoy
    		38.50% 30.95% 20.76% 30.16% 33.87% 29.23% 30.90% 22.19% 21.83% 25.66% 33.94% 17.37% 23.87% 18.50% 22.16% 38.04% 27.10% 38.84% 16.52% 24.51% 22.55% 22.90% 84.18% 91.33% 180.51%     
      qoq
    		14.27% 14.06% 0.82% 5.40% 8.04% 5.19% 8.67% 8.41% 4.29% 6.55% 1.44% 8.08% 7.57% 13.57% -11.11% 14.06% 2.91% 17.08% 0.45% 5.02% 12.41% -1.74% 7.33% 3.37% 12.73% 47.25% 11.50% 51.54%  
      costs and operating expenses:
    		                             
      cost of revenue
    		93,587,000 81,205,000 74,723,000                           
      gross profit
    		171,609,000 150,883,000 128,748,000                           
      yoy
    		                             
      qoq
    		13.74% 17.19%                            
      gross margin %
    		64.71% 65.01% 63.28% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 
      research and development expense
    		89,957,000 87,449,000 88,521,000 93,543,000 87,306,000 83,102,000 83,802,000 89,856,000 93,851,000 90,359,000 93,128,000 106,578,000 100,017,000 85,455,000 81,757,000 73,021,000 70,968,000 63,724,000 55,508,000 40,282,000 36,245,000 36,319,000 37,016,000 25,875,000 24,569,000 19,532,000 16,316,000 16,652,000 14,253,000 
      sales and marketing expense
    		127,375,000 119,588,000 104,316,000 104,763,000 97,880,000 81,867,000 80,425,000 79,127,000 68,934,000 71,043,000 76,123,000 81,423,000 80,370,000 73,603,000 64,432,000 59,599,000 50,228,000 47,716,000 34,338,000 31,288,000 25,095,000 25,015,000 25,115,000 22,287,000 18,802,000 19,439,000 17,807,000 17,114,000 13,464,000 
      general and administrative expense
    		53,266,000 50,259,000 46,952,000 51,880,000 49,129,000 40,463,000 38,651,000 37,665,000 36,174,000 41,516,000 40,445,000 37,888,000 41,121,000 43,680,000 41,267,000 40,274,000 50,055,000 48,376,000 67,935,000 69,505,000 66,294,000 37,186,000 19,785,000 18,859,000 16,440,000 13,439,000 12,661,000 12,547,000 8,129,000 
      total costs and operating expenses
    		364,185,000 338,501,000 314,512,000 327,779,000 308,804,000 277,853,000 268,174,000 352,565,000 256,573,000 256,766,000 262,769,000 273,010,000 262,004,000 239,465,000 219,437,000 206,316,000 202,067,000 189,743,000 186,528,000 169,482,000 148,821,000 120,955,000 102,422,000 88,859,000 78,325,000 69,243,000 60,319,000 60,260,000 45,897,000 
      income from operations
    		-98,989,000 -106,413,000 -111,041,000 -125,965,000 -117,328,000 -100,618,000 -99,683,000 -197,511,000 -113,543,000 -119,616,000 -134,055,000 -146,119,000 -144,600,000 -130,321,000 -123,338,000 -98,208,000 -107,288,000 -97,642,000 -107,863,000 -91,166,000 -74,252,000 -54,620,000 -34,912,000 -25,962,000 -17,477,000 -15,268,000 -23,664,000 -27,387,000 -24,205,000 
      yoy
    		-15.63% 5.76% 11.39% -36.22% 3.33% -15.88% -25.64% 35.17% -21.48% -8.21% 8.69% 48.79% 34.78% 33.47% 14.35% 7.72% 44.49% 78.77% 208.96% 251.15% 324.86% 257.74% 47.53% -5.20% -27.80%     
      qoq
    		-6.98% -4.17% -11.85% 7.36% 16.61% 0.94% -49.53% 73.95% -5.08% -10.77% -8.26% 1.05% 10.96% 5.66% 25.59% -8.46% 9.88% -9.48% 18.31% 22.78% 35.94% 56.45% 34.47% 48.55% 14.47% -35.48% -13.59% 13.15%  
      operating margin %
    		-37.33% -45.85% -54.57% -62.42% -61.28% -56.77% -59.16% -127.38% -79.38% -87.22% -104.15% -115.15% -123.16% -119.40% -128.34% -90.84% -113.20% -106.02% -137.12% -116.41% -99.57% -82.34% -51.71% -41.28% -28.72% -28.29% -64.56% -83.31% -111.58% 
      interest income
    		7,391,000 7,560,000 9,112,000 11,653,000 13,257,000 13,913,000 14,868,000 13,888,000 11,690,000 6,727,000 3,060,000 2,150,000 1,754,000 1,387,000 778,000 653,000 689,000 1,037,000 1,551,000 1,900,000 2,313,000 2,640,000 3,318,000 3,871,000 4,286,000 3,099,000 2,485,000 2,334,000 958,000 
      interest expense
    		-943,000 -983,000 -791,000 -645,000 -646,000 -645,000 -645,000 -645,000 -644,000 -645,000 -644,000 -644,000 -644,000 -645,000 -644,000 -643,000 -644,000 -644,000 -646,000 -4,736,000 -8,000 -10,000 -12,000 -321,000 -280,000 -287,000 -293,000 -299,000 -304,000 
      other income
    		-48,000 -25,000 7,851,000 4,667,000 -3,007,000 -15,145,000 -29,120,000 -3,316,000 16,885,000 41,259,000 -1,654,000 5,281,000 -18,389,000 378,000 -48,000 25,898,000 -187,000 -243,000 -290,000 1,220,000 345,000 2,285,000 -209,000 -187,000 179,000 -51,000 147,000 115,000 43,000 
      income before benefit from income taxes
    		-92,589,000 -99,861,000 -94,869,000 -110,290,000 -107,724,000 -102,495,000 -114,580,000 -187,584,000 -85,612,000 -72,275,000 -133,293,000 -139,332,000 -161,879,000 -228,986,000 -123,252,000 -72,300,000 -107,430,000 -97,492,000 -107,248,000 -92,782,000 -71,602,000 -49,705,000 -31,815,000 -22,599,000 -13,292,000 -12,507,000 -21,325,000 -25,237,000 -23,508,000 
      benefit from income taxes
    		136,000 38,000 290,000 716,000 30,000 133,000 405,000 -541,000 490,000 496,000 240,000 602,000 115,000 446,000 -24,000 11,000 96,000 83,000 110,000 263,000 68,000 34,000 14,000 -489,000 -202,000 -1,207,000 26,000 35,000  
      net income
    		-92,725,000 -99,899,000 -95,159,000 -111,006,000 -107,754,000 -102,628,000 -114,985,000 -187,043,000 -86,102,000 -72,771,000 -133,533,000 -139,934,000 -161,994,000 -229,432,000 -123,228,000 -72,311,000 -107,526,000 -97,575,000 -107,358,000 -93,045,000 -71,670,000 -49,739,000 -31,829,000 -22,110,000 -13,090,000 -11,300,000 -21,351,000 -25,272,000 -23,508,000 
      yoy
    		-13.95% -2.66% -17.24% -40.65% 25.15% 41.03% -13.89% 33.67% -46.85% -68.28% 8.36% 93.52% 50.66% 135.13% 14.78% -22.28% 50.03% 96.17% 237.30% 320.83% 447.52% 340.17% 49.07% -12.51% -44.32%     
      qoq
    		-7.18% 4.98% -14.28% 3.02% 4.99% -10.75% -38.52% 117.23% 18.32% -45.50% -4.57% -13.62% -29.39% 86.18% 70.41% -32.75% 10.20% -9.11% 15.38% 29.82% 44.09% 56.27% 43.96% 68.91% 15.84% -47.08% -15.52% 7.50%  
      net income margin %
    		-34.96% -43.04% -46.77% -55.00% -56.28% -57.91% -68.24% -120.63% -60.20% -53.06% -103.74% -110.28% -137.98% -210.21% -128.23% -66.89% -113.45% -105.94% -136.47% -118.81% -96.11% -74.98% -47.15% -35.15% -21.51% -20.94% -58.25% -76.88% -108.37% 
      net income per share
    		-0.74 -0.8 -0.77 -0.9 -0.88 -0.84 -0.94 -1.62 -0.73 -0.67 -1.3 -1.37 -1.58 -2.25 -1.21 -0.89 -1.06 -0.96 -1.09 -0.94 -0.78 -0.57 -0.29 -0.28 -0.14 -0.13 -0.3 2.07 -1.94 
      weighted-average shares used for eps calculation
    		124,807 124,114 123,871 122,745 123,051 122,447 121,712 111,988 117,736 108,808 102,663 102,178 102,289 102,047 101,853 101,314 101,420 101,172 100,955 97,504 99,554 96,011 94,382 90,597 93,303 89,036 85,935 30,403 12,582 
      revenue:
    		                             
      precision oncology testing
    		   184,585,000 180,604,000 166,518,000 156,229,000 142,189,000 133,423,000 125,244,000 113,393,000 113,797,000 102,054,000 92,062,000 84,136,000 88,707,000 79,272,000 72,604,000 63,729,000 64,703,000 60,384,000 50,991,000 60,246,000 57,414,000 52,147,000 42,064,000 28,837,000 28,096,000 18,298,000 
      development services and other
    		   17,229,000 10,872,000 10,717,000 12,262,000 12,865,000 9,607,000 11,906,000 15,321,000 13,094,000 15,350,000 17,082,000 11,963,000 19,401,000 15,507,000 19,497,000 14,936,000 13,613,000 14,185,000         
      cost of precision oncology testing
    		   69,465,000 66,095,000 65,715,000 59,306,000 57,417,000 53,648,000 49,357,000 45,106,000 43,706,000 39,434,000 34,375,000 30,684,000 32,254,000 29,665,000 24,887,000 23,590,000 22,070,000 16,699,000 17,809,000 18,191,000 20,004,000 16,578,000 14,650,000 11,023,000 12,624,000 9,671,000 
      cost of development services and other
    		   8,128,000 8,394,000 6,706,000 5,990,000 5,100,000 3,966,000 4,491,000 7,967,000 3,415,000 1,062,000 2,352,000 1,297,000 1,168,000 1,151,000 5,040,000 5,157,000 6,337,000 4,488,000         
      fair value adjustments of noncontrolling interest liability
    		             -99,785,000                
      adjustment of redeemable noncontrolling interest
    		               -18,600,000   -2,300,000 -700,000 -6,000,000 -4,900,000 4,100,000       
      net income attributable to guardant health, inc. common stockholders
    		           -139,934,000 -161,994,000 -229,432,000 -123,228,000 -90,911,000 -107,526,000 -97,575,000 -109,658,000 -93,745,000 -77,670,000 -54,639,000 -27,729,000 -25,210,000 -12,790,000 -11,600,000 -26,051,000 -25,122,000 -24,458,000 
      development services
    		                     15,344,000 7,264,000 5,483,000 8,701,000 11,911,000 7,818,000 4,777,000 3,394,000 
      cost of development services
    		                     4,626,000 2,315,000 1,834,000 1,936,000 2,183,000 2,512,000 1,323,000 380,000 
      fair value adjustment of redeemable noncontrolling interest
    		                       -1,175,000 300,000 -300,000 -4,700,000 150,000 -950,000 
      loss on debt extinguishment
    		                             
      net income attributable to guardant health, inc.
    		                           -25,122,000 -24,458,000 
      deemed dividend related to repurchase of series a convertible preferred stock
    		                             
      deemed dividend related to change in conversion rate of series d convertible preferred stock
    		                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.